Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2

Clinical trial NCT04907331 · UNKNOWN

Trial details

NCT number: NCT04907331
Sponsor: Medical University Innsbruck
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV2 Infection

Start date: 2021-05-10
Primary completion: 2021-11-30
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.